SK life science is committed to accelerating the development of next generation treatments for CNS disorders. SK Biopharmaceuticals and SK life science independently developed XCOPRI® from inception through to FDA approval.
Invigorating next-generation discovery
We are a group of scientists, inventors, and explorers working to unlock the complex mysteries of the brain
